The Inhalation Preparation Market faces unique and complex challenges in generic development where demonstrating bioequivalence between innovator and generic inhaled products requires far more than the pharmacokinetic studies sufficient for oral medications. The device-formulation combination in inhalers means that seemingly minor changes in either component can significantly alter lung...